BlackRock’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.8M Sell
3,698,756
-129,714
-3% -$695K ﹤0.01% 2983
2025
Q1
$20.4M Sell
3,828,470
-68,395
-2% -$365K ﹤0.01% 2896
2024
Q4
$34.8M Buy
3,896,865
+397,387
+11% +$3.55M ﹤0.01% 2652
2024
Q3
$38.5M Sell
3,499,478
-18,102
-0.5% -$199K ﹤0.01% 2605
2024
Q2
$32M Sell
3,517,580
-67,913
-2% -$618K ﹤0.01% 2664
2024
Q1
$50.5M Buy
3,585,493
+1,400,935
+64% +$19.7M ﹤0.01% 2391
2023
Q4
$16.8M Buy
2,184,558
+495,722
+29% +$3.81M ﹤0.01% 3048
2023
Q3
$12.6M Buy
1,688,836
+36,326
+2% +$271K ﹤0.01% 3142
2023
Q2
$13.8M Buy
1,652,510
+1,364,141
+473% +$11.4M ﹤0.01% 3191
2023
Q1
$3.84M Buy
288,369
+196,770
+215% +$2.62M ﹤0.01% 3671
2022
Q4
$1.36M Buy
91,599
+13,274
+17% +$198K ﹤0.01% 4220
2022
Q3
$708K Buy
78,325
+16,868
+27% +$152K ﹤0.01% 4525
2022
Q2
$185K Buy
61,457
+11,071
+22% +$33.3K ﹤0.01% 4964
2022
Q1
$338K Sell
50,386
-2,687
-5% -$18K ﹤0.01% 4891
2021
Q4
$287K Buy
53,073
+11,957
+29% +$64.7K ﹤0.01% 4946
2021
Q3
$363K Buy
41,116
+1,780
+5% +$15.7K ﹤0.01% 4778
2021
Q2
$497K Sell
39,336
-163,827
-81% -$2.07M ﹤0.01% 4628
2021
Q1
$3.52M Buy
203,163
+8,699
+4% +$151K ﹤0.01% 4027
2020
Q4
$2.5M Buy
194,464
+8,569
+5% +$110K ﹤0.01% 3894
2020
Q3
$6.9M Buy
185,895
+1,209
+0.7% +$44.9K ﹤0.01% 3339
2020
Q2
$7.13M Buy
184,686
+145,147
+367% +$5.6M ﹤0.01% 3309
2020
Q1
$985K Buy
39,539
+2,232
+6% +$55.6K ﹤0.01% 3802
2019
Q4
$1.32M Buy
37,307
+9,009
+32% +$319K ﹤0.01% 3857
2019
Q3
$917K Sell
28,298
-482
-2% -$15.6K ﹤0.01% 3960
2019
Q2
$1.39M Buy
28,780
+18,744
+187% +$907K ﹤0.01% 3847
2019
Q1
$476K Buy
+10,036
New +$476K ﹤0.01% 4058
2018
Q4
Sell
-2,838
Closed -$136K 4903
2018
Q3
$136K Buy
2,838
+1,656
+140% +$79.4K ﹤0.01% 4336
2018
Q2
$68K Buy
1,182
+602
+104% +$34.6K ﹤0.01% 4466
2018
Q1
$63K Sell
580
-11
-2% -$1.2K ﹤0.01% 4362
2017
Q4
$53K Buy
591
+25
+4% +$2.24K ﹤0.01% 4367
2017
Q3
$72K Sell
566
-22
-4% -$2.8K ﹤0.01% 4349
2017
Q2
$50K Buy
588
+260
+79% +$22.1K ﹤0.01% 4454
2017
Q1
$32K Buy
+328
New +$32K ﹤0.01% 4469